The value of [18F]FET PET and somatostatin receptor imaging for differentiating pseudoprogression in residual meningioma

Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1194-1196. doi: 10.1007/s00259-023-06479-8. Epub 2023 Oct 28.
No abstract available

MeSH terms

  • Brain Neoplasms*
  • Glioma*
  • Humans
  • Magnetic Resonance Imaging
  • Meningeal Neoplasms* / diagnostic imaging
  • Meningioma* / diagnostic imaging
  • Positron-Emission Tomography / methods
  • Receptors, Somatostatin
  • Tyrosine

Substances

  • Receptors, Somatostatin
  • Tyrosine